2023 Form 5500 filing — Tizona Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240916161516NAL0000734883001) for Tizona Therapeutics, Inc. 401(K) Plan, reported by Tizona Therapeutics, Inc. under EIN 47-2105555 and plan number 001. It reports 67 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$5.7MReported net assets$5,704,962
Participants67
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20240916161516NAL0000734883001
Plan sponsor
Tizona Therapeutics, Inc.
EIN
47-2105555
Plan number
001
Location
South San Francisco, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$5.7M total assets
Net assets$5.7MLiabilities$0
Money in vs. money out
Total income / additions$2.1M
Total expenses$420.9K
Benefits paid / distributions$420.6K
Contributions
Employer$207.7K
Participant$743.2K
Full reported line items
Total assets (EOY)
$5,704,962
Total liabilities (EOY)
$0
Net assets (EOY)
$5,704,962
Employer contributions
$207,711
Participant contributions
$743,230
Total income / additions
$2,054,856
Benefits paid
$420,620
Administrative expenses
$275
Total expenses
$420,895
Net increase / (decrease)
$1,633,961

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20240916161516NAL0000734883001 cover?
It is the 2023 Form 5500 filing for Tizona Therapeutics, Inc. 401(K) Plan, reported by Tizona Therapeutics, Inc. (EIN 47-2105555).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages